Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysbiosis of gut microbiota in patients with esophageal cancer
Yali Deng, Derong Tang, Pan‐Fei Hou, et al.
Microbial Pathogenesis (2020) Vol. 150, pp. 104709-104709
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Malignant Tumors in Vagal-innervated Organs: Exploring Its Homeostatic Role
Pierrick Martinez, Jean‐Marc Sabatier
Cancer Letters (2025), pp. 217539-217539
Closed Access | Times Cited: 2
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim, Helena Kupcová Skalníková, Jana Čížková, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 67
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Annemieke Smet, Juozas Kupčinskas, Alexander Link, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 857-874
Open Access | Times Cited: 59
Antigenotoxicity and Cytotoxic Potentials of Cell-Free Supernatants Derived from Saccharomyces cerevisiae var. boulardii on HT-29 Human Colon Cancer Cell Lines
Amin Abbasi, Aziz Homayouni Rad, Leili Aghebati‐Maleki, et al.
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 6, pp. 1583-1595
Closed Access | Times Cited: 25
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 12
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer
Julie Véziant, Romain Villéger, Nicolas Barnich, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2215-2215
Open Access | Times Cited: 48
Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non‐small cell lung cancer
Qian Xiang, Hongyan Zhang, Qinglin Li, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 37
Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study
Zhichen Jiang, Yiping Mou, Hui‐Ju Wang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Modified Gexia-Zhuyu Tang inhibits gastric cancer progression by restoring gut microbiota and regulating pyroptosis
Tingting Zhao, Zhijian Yu
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Integrated Bacterial and Fungal Diversity Analysis Reveals the Gut Microbial Alterations in Diarrheic Giraffes
Jiakui Li, Bingxian Liu, Feiran Li, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 40
Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer
Changchang Chen, Linjie Chen, Lijun Lin, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 11, pp. 4415-4425
Closed Access | Times Cited: 34
Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma
Yang Chen, Junjie Ma, Yunze Dong, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 28
Esophageal cancer and bacterial part of gut microbiota – A multidisciplinary point of view
Damian Muszyński, Anna Kudra, Bartosz Kamil Sobocki, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 25
Alterations in gut microbiota of esophageal squamous cell carcinoma patients
Man Kit Cheung, Grace Gar‐Lee Yue, Susana Lauw, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 10, pp. 1919-1927
Closed Access | Times Cited: 23
The Role of the Microbiota in Esophageal Cancer
Clara Moreira, Céu Figueiredo, Rui M. Ferreira
Cancers (2023) Vol. 15, Iss. 9, pp. 2576-2576
Open Access | Times Cited: 13
Extraction and characterization of polysaccharide from fermented mycelia of Coriolus versicolor and its efficacy for treating nonalcoholic fatty liver disease
Huiling Tang, Zhengqi Zha, Yanfang Tan, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125951-125951
Closed Access | Times Cited: 13
Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma
Mingjun Gao, Jun Wu, Siding Zhou, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
Roles of Microbiota in Cancer: From Tumor Development to Treatment
Zohreh Bagheri, Leila Moeinzadeh, Mahboobeh Razmkhah
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 22
Characteristics of the Intestinal Microorganisms in Middle-Aged and Elderly Patients: Effects of Smoking
Haitao Yang, Wen‐Juan Xiu, Jing‐Kun Liu, et al.
ACS Omega (2022) Vol. 7, Iss. 2, pp. 1628-1638
Open Access | Times Cited: 20
Awareness of intratumoral bacteria and their potential application in cancer treatment
Liang Yin, Qiyan Li, Yulin Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Effects of Perfluorooctanoic Acid on Gut Microbiota and Microbial Metabolites in C57BL/6J Mice
Bei Gao, Lixia Chen, Weichen Xu, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 707-707
Open Access | Times Cited: 12
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Cheng Chen, Ana Beloqui, Yining Xu
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115117-115117
Closed Access | Times Cited: 12
Exploring the gut microbiome and head and neck cancer interplay
Veeksha V Shetty, Shilpa S. Shetty
Pathology - Research and Practice (2024) Vol. 263, pp. 155603-155603
Closed Access | Times Cited: 4
Gut Microbiome and Metabolite Characteristics Associated With Different Clinical Stages in Non-Small Cell Lung Cancer Patients
Fan Liu, Xingbing Lu, Miaoling Tang, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 45-56
Open Access
Page 1 - Next Page

Scroll to top